Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation | MicrobiomeTrials← Back to trialsNCT04902807
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
CompletedOBSERVATIONAL
Trial Details
Start: 2021-09-07Est. Completion: 2025-05-14
Enrollment target: 325 participants Locations- hôpital Necker Enfants Malades, Paris, France
Other microbiome trials you might be interested in
XLACVIDYao SyndromeBlau Syndrome
This study aims to understand the causes and progression of Common Variable Immunodeficiency (CVID) and related inborn e…
Bethesda, United States
Primary T-cell Immunodeficiency DisordersCommon Variable ImmunodeficiencyImmune System DiseasesAutoimmune LymphoproliferativeLymphoproliferative Disorders
Background:
Allogeneic blood or marrow transplant is when stem cells are taken from one person s blood or bone marrow a…
Bethesda, United StatesEst. completion Dec 31, 2031
Lupus NephritisImmunoglobulin A NephropathyMembranous NephropathyAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
The goal of this clinical study is to evaluate multiple dose levels of povetacicept in adults with immunoglobulin A (IgA…
Phoenix, United StatesEst. completion Mar 2, 2028